The pathogenesis of biliary atresia: Evidence for a virus-induced autoimmune disease

Seminars in Liver Disease

Volumn 27, Issue 3, 2007, Pages 233-242

  Mack, Cara L ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

Adaptive immunity; Cholangitis; Neonatal immunity; Reovirus; Rotavirus

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; GRANZYME A; HLA A24 ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; PERFORIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BILE DUCT ATRESIA; BILE DUCT INJURY; BYSTANDER EFFECT; CELLULAR IMMUNITY; CHOLESTASIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FAMILY HISTORY; FRENCH POLYNESIA; HAPLOTYPE; HEALTH CARE COST; HUMAN; HUMAN HERPESVIRUS 6; HUMORAL IMMUNITY; IMMUNE MEDIATED INJURY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; PORTOENTEROSTOMY; PRIORITY JOURNAL; REOVIRUS; REVIEW; ROTAVIRUS; STATISTICAL ANALYSIS; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; TAIWAN; TARGET ORGAN; TREATMENT RESPONSE; UNITED STATES; VIRUS PATHOGENESIS; WART VIRUS;

ANIMALS; AUTOIMMUNITY; BILIARY ATRESIA; CYTOMEGALOVIRUS; HUMANS; MICE; RATS; REOVIRIDAE;

EID: 34548131082     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985068     Document Type: Review

References (86)

1. Chen SM, Chang MH, Du JC, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics 2006;117:1147-1154
2. Hung PY, Chen CC, Chen WJ, et al. Long-term prognosis of patients with biliary atresia: a 25 year summary. J Pediatr Gastroenterol Nutr 2006;42:190-195
3. Sokol RJ, Mack CL. Etiopathogenesis of biliary atresia. Semin Liver Dis 2001;21:517-524
4. Balistreri WF, Grand R, Hoofnagle J, et al. Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology 1996;23:1682-1692
5. Gosseye S, Otte JB, De Meyer R, Maldague P. A histological study of extrahepatic biliary atresia. Acta Paediatr Belg 1977;30:85-90
6. Ohya T, Fujimoto T, Shimomura H, et al. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg 1995;30:515-518
7. Sokol RJ, Mack CL, Narkewicz MR, Karrer FM. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr 2003;37:4-21
8. Lykavieris P, Chardot C, Sokhn M, et al. Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver. Hepatology 2005;41:366-371
9. Bucuvalas JC, Ryckman FC, Atherton H, et al. Predictors of cost of liver transplantation in children: a single center study. J Pediatr 2001;139:66-74
10. Riepenhoff-Talty M, Houvea V, Evans MJ, et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 1996;174:8-15
11. Morecki R, Glaser JH, Cho S, Balistreri WF, Horwitz MS. Biliary atresia and reovirus type 3 infection. N Engl J Med 1982;307:481-484
12. Tyler KL, Sokol RJ, Oberhaus SM, et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 1998;27:1475-1482
13. Jevon GP, Kimmick JE. Biliary atresia and cytomegalovirus infection: a DNA study. Pediatr Dev Pathol 1999;2:11-14
14. Schreiber RA, Kleinman RE. Genetics, immunology, and biliary atresia: an opening or a diversion? J Pediatr Gastroenterol Nutr 1993;16:111-113
15. Tan CE, Driver M, Howard ER, et al. Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry. J Pediatr Surg 1994;29:808-814
16. Oldstone MB. Molecular and cellular mechanisms, pathogenesis, and treatment of insulin-dependent diabetes obtained through study of a transgenic model of molecular mimicry. Curr Top Microbiol Immunol 2005;296:65-87
17. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med 2001;7:899-905
18. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985;230:1043-1045
19. Naucler CS, Larsson S, Moller E. A novel mechanism for virus-induced autoimmunity in humans. Immunol Rev 1996;152:175-192
20. Fae KC, da Silva DD, Oshiro SE, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 2006;176:5662-5670
21. Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol 2005;175:5448-5456
22. Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 2006;39:63-70
23. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-705
24. Rao VP, Kajon AE, Spindler KR, Carayanniotis G. Involvement of epitope mimicry in potentiation but not initiation of autoimmune disease. J Immunol 1999;162:5888-5893
25. Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD. A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest 2001;108:311-318
26. Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998;279:1344-1347
27. Beisel KW, Srinivasappa J, Prabhakar BS. Identification of a putative shared epitope between Coxsackie virus B4 and alpha cardiac myosin heavy chain. Clin Exp Immunol 1991;86:49-55
28. Drut R, Drut RM, Gomez MA, et al. Presence of human papillomavirus in extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1998;27:530-535
29. Domiati-Saad R, Dawson DB, Margraf LR, et al. Cytomegalovirus and human herpesvirus 6, but not human papillomavirus, are present in neonatal giant cell hepatitis and extrahepatic biliary atresia. Pediatr Dev Pathol 2000;3:367-373
30. Fjaer RB, Bruu AL, Nordbo SA. Extrahepatic bile duct atresia and viral involvement. Pediatr Transplant 2005;9:68-73
31. Glaser JH, Balistreri WF, Morecki R. Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr 1984;105:912-915
32. Richardson SC, Bishop RF, Smith AL. Reovirus serotype 3 infection in infants with extrahepatic biliary atresia or neonatal hepatitis. J Gastroenterol Hepatol 1994;9:264-268
33. Steele MI, Marshall CM, Lloyd RE, Randolph VE. Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology 1995;21:697-702
34. Saito T, Shinozaki K, Matsunaga T, et al. Lack of evidence for reovirus infection in tissues from patients with biliary atresia and congenital dilatation of the bile duct. J Hepatol 2004;40:203-211
35. Papadimitriou JM. The biliary tract in acute murine reovirus 3 infection. Am J Pathol 1968;52:595-611
36. Bangaru B, Morecki R, Glaser JH, Gartner LM, Horwitz MS. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest 1980;43:456-462
37. Parashar K, Tarlow MJ, McCrae MA. Experimental reovirus type 3-induced murine biliary tract disease. J Pediatr Surg 1992;27:843-847
38. Wilson GA, Morrison LA, Fields BN. Association of the reovirus SI gene with serotype 3-induced biliary atresia in mice. J Virol 1994;68:6458-6465
39. Barton ES, Youree BE, Ebert DH, et al. Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J Clin Invest 2003;111:1823-1833
40. Rosenberg DP, Morecki R, Lollini LO, Glaser J, Cornelius CE. Extrahepatic biliary atresia in a rhesus monkey (Macaca mulatta). Hepatology 1983;3:577-580
41. Gilger MA, Matson DO, Conner ME, et al. Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr 1992;120:912-917
42. Qiao H, Zhaori G, Jiang Z, et al. Detection of group C rotavirus antigen in bile duct and liver tissues of an infant with extrahepatic biliary atresia. Chin Med J (Engl) 1999;112:93-95
43. Bobo L, Ojeh C, Chiu D, et al. Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia. Pediatr Res 1997;41:229-234
44. Riepenhoff-Talty M, Schaekel K, Clark HF, et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 1993;33:394-399
45. Petersen C, Biermanns D, Kuske M, et al. New aspects in a murine model for extrahepatic biliary atresia. J Pediatr Surg 1997;32:1190-1195
46. Petersen C, Grassholl S, Luciano L. Diverse morphology of biliary atresia in an animal model. J Hepatol 1998;28:603-607
47. Czech-Schmidt G, Verhagen W, Szavay P, et al. Immunological gap in the infectious animal model for biliary atresia. J Surg Res 2001;101:62-67
48. + effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol 2005;115:200-209
49. Allen SR, Jafri M, Donnelly B, et al. Effect of rotavirus strain on the murine model of biliary atresia. J Virol 2007;81:1671-1679
50. Ko HM, Kim KS, Park JW, et al. Congenital cytomegalovirus infection: three autopsy case reports. J Korean Med Sci 2000;15:337-432
51. Martelius T, Krogerus L, Hockerstedt K, Bruggeman C, Lautenschlager I. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology 1998;27:996-1002
52. Evans PC, Coleman N, Wreghitt TG, Wight DG, Alexandder GJ. Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts. J Hepatol 1999;31:913-920
53. De Tommaso AM, Andrade PD, Costa S, Escanhoela C, Hessel G. High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis. BMC Infect Dis 2005;5:108
54. Fischler B, Ehrnst A, Forsgren M, Orvell C, Nemeth A. The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1998;27:57-64
55. Dillon PW, Belchis D, Minnick K, Tracy T. Differential expression of the major histocompatibility antigens and ICAM-1 on bile duct epithelial cells in biliary atresia. Tohoku J Exp Med 1997;181:33-40
56. Broome U, Nemeth A, Hultcrantz R, Scheynius A. Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease. J Hepatol 1997;26:857-862
57. Davenport M, Gonde C, Redkar R, et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg 2001;36:1017-1025
58. + T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis. J Pathol 2001;193:383-389
59. + Th1 cell-mediated portal tract inflammation. Pediatr Res 2004;56:79-87
60. Ohya T, Fujimoto T, Shimomura H, Miyano T. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg 1995;30:515-518
61. + T cells in the target organ of patients with biliary atresia. Gastroenterology 2007; doi: 10.1053/j.gastro.2007.04.032
62. Bezerra JA, Tiao G, Ryckman FC, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002;360:1653-1659
63. Leonhardt J, Stanulla M, von Wasielewski R, et al. Gene expression profile of the infective murine model for biliary atresia. Pediatr Surg Int 2006;22:84-89
64. Carvalho E, Liu C, Shivakumar P, et al. Analysis of the biliary transcriptome in experimental biliary atresia. Gastroenterology 2005;129:713-717
65. Shivakumar P, Campbell KM, Sabla GE, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004;114:322-329
66. Mohanty SK, Shivakumar P, Sabla G, Bezerra JA. Loss of IL-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia. BMC Gastroenterol 2006;6:14
67. Tucker RM, Hendrickson R, Mukaida N, Gill RG, Mack CL. Progressive biliary destruction is independent of a functional TNF-α pathway in a rhesus rotavirus-induced murine model of biliary atresia. Viral Immunol 2007;20:34-43
68. Hadchouel M, Hugon RN, Odievre M. Immunoglobulin deposits in the biliary remnants of extrahepatic biliary atresia: a study by immunoperoxidase staining in 128 infants. Histopathology 1981;5:217-221
69. Vasiliauskas E, Targan S, Cobb L, Vidrich A, Rosenthal P. Biliary atresia: an autoimmune disorder? Hepatology 1995;22:87 (Abstract)
70. Burch JM, Sokol RJ, Narkewicz MR, et al. Autoantibodies in mothers of children with neonatal liver disease. J Pediatr Gastroenterol Nutr 2003;37:262-267
71. Mack CL, Tucker RM, Lu BR, et al. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 2006;44:1231-1239
72. Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyroiditis and autoimmunization. J Am Med Assoc 1957;164:1439-1447
73. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993;14:426-430
74. Kerkar N, Hadzic N, Davies E, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351:409-413
75. Gupta P, Hart J, Millis JM, Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001;71:664-668
76. Broome U, Nemeth A, Hultcrantz R, et al. Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease. J Hepatol 1997;26:857-862
77. Feng J, Li M, Hu W, Tang H, Yu S. The aberrant expression of HLA-DR in intrahepatic bile ducts in patients with biliary atresia: an immunohistochemistry and immune electron microscopy study. J Pediatr Surg 2004;39:1658-1662
78. Donaldson PT, Clare M, Constantini PK, et al. HLA and cytokine gene polymorphisms in biliary atresia. Liver 2002;22:213-219
79. Yuasa T, Tsuji H, Kimura S, et al. Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantation. Hum Immunol 2005;66:295-300
80. A-Kader HH, El-Ayyouti M, Hawas S, et al. HLA in Egyptian children with biliary atresia. J Pediatr 2002;141:432-433
81. Dillon PW, Owings E, Cilley R, et al. Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg 2001;36:80-85
82. Meyers RL, Book LS, O'Gorman MA, et al. High-dose steroids, ursodeoxycholic acid and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg 2003;38:406-411
83. Muraji T, Nio M, Ohhama Y, et al. Postoperative corticosteroid therapy for bile drainage in biliary atresia: a nationwide study. J Pediatr Surg 2004;39:1803-1805
84. Kobayashi H, Yamataka A, Koga H, et al. Optimum prednisolone useage in patients with biliary atresia postportoenterostomy. J Pediatr Surg 2005;40:327-330
85. Escobar MA, Jay CL, Brooks RM, et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 2006;41:99-103
86. Sokol RJ. New North American research network focuses on biliary atresia and neonatal liver disease. J Pediatr Gastroenterol Nutr 2003;36:1